Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology.

Woods JJ, Skelding KA, Martin KL, Aryal R, Sontag E, Johnstone DM, Horvat JC, Hansbro PM, Milward EA.

Brain Behav Immun. 2019 Oct 15. pii: S0889-1591(19)30454-4. doi: 10.1016/j.bbi.2019.10.014. [Epub ahead of print] Review.

PMID:
31626972
2.

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets.

Taylor OG, Brzozowski JS, Skelding KA.

Front Oncol. 2019 Sep 26;9:963. doi: 10.3389/fonc.2019.00963. eCollection 2019. Review.

3.

The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase (CaMK) Family: Emerging Targets for Anti-Cancer Therapeutic Intervention.

Brzozowski JS, Skelding KA.

Pharmaceuticals (Basel). 2019 Jan 7;12(1). pii: E8. doi: 10.3390/ph12010008. Review.

4.

Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines.

Brzozowski JS, Jankowski H, Bond DR, McCague SB, Munro BR, Predebon MJ, Scarlett CJ, Skelding KA, Weidenhofer J.

Lipids Health Dis. 2018 Sep 8;17(1):211. doi: 10.1186/s12944-018-0854-x.

5.

Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion.

Brzozowski JS, Bond DR, Jankowski H, Goldie BJ, Burchell R, Naudin C, Smith ND, Scarlett CJ, Larsen MR, Dun MD, Skelding KA, Weidenhofer J.

Sci Rep. 2018 Jun 11;8(1):8822. doi: 10.1038/s41598-018-27180-z.

6.

The Role of DNA Repair Pathways in AML Chemosensitivity.

Pearsall EA, Lincz LF, Skelding KA.

Curr Drug Targets. 2018;19(10):1205-1219. doi: 10.2174/1389450119666180110093713. Review.

PMID:
29318968
7.

Management of acute coronary syndromes: special considerations in women.

Madonis SM, Skelding KA, Roberts M.

Heart. 2017 Oct;103(20):1638-1646. doi: 10.1136/heartjnl-2016-309938. Review. No abstract available.

PMID:
28970234
8.

Trends and Outcomes After Same-Day Discharge After Percutaneous Coronary Interventions.

Agarwal S, Thakkar B, Skelding KA, Blankenship JC.

Circ Cardiovasc Qual Outcomes. 2017 Aug;10(8). pii: e003936. doi: 10.1161/CIRCOUTCOMES.117.003936.

PMID:
28794119
9.

Renin angiotensin system inhibitors: a panacea for heart disease?

Al-Azizi KM, Skelding KA.

J Thorac Dis. 2017 Jun;9(6):1437-1439. doi: 10.21037/jtd.2017.05.65. No abstract available.

10.

The role of Ca2+-calmodulin stimulated protein kinase II in ischaemic stroke - A potential target for neuroprotective therapies.

Rostas JAP, Spratt NJ, Dickson PW, Skelding KA.

Neurochem Int. 2017 Jul;107:33-42. doi: 10.1016/j.neuint.2017.01.012. Epub 2017 Jan 31. Review.

PMID:
28153786
11.

Ischaemia- and excitotoxicity-induced CaMKII-Mediated neuronal cell death: The relative roles of CaMKII autophosphorylation at T286 and T253.

Rostas JA, Hoffman A, Murtha LA, Pepperall D, McLeod DD, Dickson PW, Spratt NJ, Skelding KA.

Neurochem Int. 2017 Mar;104:6-10. doi: 10.1016/j.neuint.2017.01.002. Epub 2017 Jan 5.

PMID:
28065796
12.

Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.

Dewey FE, Murray MF, Overton JD, Habegger L, Leader JB, Fetterolf SN, O'Dushlaine C, Van Hout CV, Staples J, Gonzaga-Jauregui C, Metpally R, Pendergrass SA, Giovanni MA, Kirchner HL, Balasubramanian S, Abul-Husn NS, Hartzel DN, Lavage DR, Kost KA, Packer JS, Lopez AE, Penn J, Mukherjee S, Gosalia N, Kanagaraj M, Li AH, Mitnaul LJ, Adams LJ, Person TN, Praveen K, Marcketta A, Lebo MS, Austin-Tse CA, Mason-Suares HM, Bruse S, Mellis S, Phillips R, Stahl N, Murphy A, Economides A, Skelding KA, Still CD, Elmore JR, Borecki IB, Yancopoulos GD, Davis FD, Faucett WA, Gottesman O, Ritchie MD, Shuldiner AR, Reid JG, Ledbetter DH, Baras A, Carey DJ.

Science. 2016 Dec 23;354(6319). pii: aaf6814. doi: 10.1126/science.aaf6814.

PMID:
28008009
13.

Women and Calcium: A Love-Hate Relationship at the Center of the Heart.

Grines CL, Skelding KA.

JACC Cardiovasc Interv. 2016 Sep 26;9(18):1902-4. doi: 10.1016/j.jcin.2016.08.008. No abstract available.

14.

Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells.

Chi M, Evans H, Gilchrist J, Mayhew J, Hoffman A, Pearsall EA, Jankowski H, Brzozowski JS, Skelding KA.

Sci Rep. 2016 Sep 8;6:33132. doi: 10.1038/srep33132.

15.

Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).

Skelding KA, Yakubov SJ, Kleiman NS, Reardon MJ, Adams DH, Huang J, Forrest JK, Popma JJ.

Am J Cardiol. 2016 Aug 15;118(4):560-6. doi: 10.1016/j.amjcard.2016.05.051. Epub 2016 May 28.

PMID:
27381665
16.

Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials).

Forrest JK, Adams DH, Popma JJ, Reardon MJ, Deeb GM, Yakubov SJ, Hermiller JB Jr, Huang J, Skelding KA, Lansky A.

Am J Cardiol. 2016 Aug 1;118(3):396-402. doi: 10.1016/j.amjcard.2016.05.013. Epub 2016 May 14.

PMID:
27346591
17.

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors.

Smith AM, Dun MD, Lee EM, Harrison C, Kahl R, Flanagan H, Panicker N, Mashkani B, Don AS, Morris J, Toop H, Lock RB, Powell JA, Thomas D, Guthridge MA, Moore A, Ashman LK, Skelding KA, Enjeti A, Verrills NM.

Oncotarget. 2016 Jul 26;7(30):47465-47478. doi: 10.18632/oncotarget.10167.

18.

Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.

Kahlon TS, Barn K, Akram MM, Blankenship JC, Bower-Stout C, Carey DJ, Sun H, Tompkins Weber K, Skelding KA, Scott TD, Green SM, Berger PB.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):245-251. doi: 10.1002/ccd.26567. Epub 2016 May 3.

PMID:
27142567
19.

Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry.

Baber U, Giustino G, Wang T, Grines C, McCoy LA, Saha-Chaudhuri P, Best P, Skelding KA, Ortega R, Chieffo A, Mehilli J, Tcheng J, Mehran R.

Coron Artery Dis. 2016 Sep;27(6):442-8. doi: 10.1097/MCA.0000000000000376.

PMID:
27100661
20.

Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry®.

Wang TY, Grines C, Ortega R, Dai D, Jacobs AK, Skelding KA, Mauri L, Mehran R.

Catheter Cardiovasc Interv. 2016 Mar;87(4):663-8. doi: 10.1002/ccd.26118. Epub 2015 Aug 10.

PMID:
26255880
21.

Does Preoperative Platelet Function Predict Bleeding in Patients Undergoing Off Pump Coronary Artery Bypass Surgery?

Berger PB, Kirchner HL, Wagner ES, Ismail-Sayed I, Yahya S, Benoit C, Blankenship JC, Carter R, Casale AS, Green SM, Scott TD, Skelding KA, Woods E, Henry YM.

J Interv Cardiol. 2015 Jun;28(3):223-32. doi: 10.1111/joic.12200. Epub 2015 May 20.

PMID:
25991082
22.

Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.

Baker NC, O'Connell EW, Htun WW, Sun H, Green SM, Skelding KA, Blankenship JC, Scott TD, Berger PB.

Am Heart J. 2014 Oct;168(4):537-44. doi: 10.1016/j.ahj.2014.06.016. Epub 2014 Jul 3.

PMID:
25262264
23.

Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusion.

Kumar AH, Martin K, Doyle B, Huang CL, Pillai GK, Ali MT, Skelding KA, Wang S, Gleeson BM, Jahangeer S, Ritman EL, Russell SJ, Caplice NM.

Biomaterials. 2014 Oct;35(32):9012-22. doi: 10.1016/j.biomaterials.2014.07.016. Epub 2014 Aug 2.

24.

Excitotoxic stimulation of brain microslices as an in vitro model of stroke.

Skelding KA, Arellano JM, Powis DA, Rostas JA.

J Vis Exp. 2014 Feb 4;(84):e51291. doi: 10.3791/51291.

25.

Dephosphorylation of CaMKII at T253 controls the metaphase-anaphase transition.

Hoffman A, Carpenter H, Kahl R, Watt LF, Dickson PW, Rostas JA, Verrills NM, Skelding KA.

Cell Signal. 2014 Apr;26(4):748-56. doi: 10.1016/j.cellsig.2013.12.015. Epub 2014 Jan 7.

PMID:
24407174
26.

Best practices for transradial angiography and intervention: a consensus statement from the society for cardiovascular angiography and intervention's transradial working group.

Rao SV, Tremmel JA, Gilchrist IC, Shah PB, Gulati R, Shroff AR, Crisco V, Woody W, Zoghbi G, Duffy PL, Sanghvi K, Krucoff MW, Pyne CT, Skelding KA, Patel T, Pancholy SB; Society for Cardiovascular Angiography and Intervention's Transradial Working Group.

Catheter Cardiovasc Interv. 2014 Feb;83(2):228-36. doi: 10.1002/ccd.25209. Epub 2013 Oct 23. No abstract available.

PMID:
24123781
27.

Readmission in the 30 days after percutaneous coronary intervention.

Yost GW, Puher SL, Graham J, Scott TD, Skelding KA, Berger PB, Blankenship JC.

JACC Cardiovasc Interv. 2013 Mar;6(3):237-44. doi: 10.1016/j.jcin.2012.10.015.

28.

Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years.

Forrest JK, Lansky AJ, Meller SM, Hou L, Sood P, Applegate RJ, Wang JC, Skelding KA, Shah A, Kereiakes DJ, Sudhir K, Cristea E, Yaqub M, Stone GW.

Am J Cardiol. 2013 Jun 1;111(11):1580-6. doi: 10.1016/j.amjcard.2013.01.330. Epub 2013 Mar 15.

PMID:
23499270
29.

Frequency of coronary angiography and revascularization among men and women with myocardial infarction and their relationship to mortality at one year: an analysis of the Geisinger myocardial infarction cohort.

Skelding KA, Boga G, Sartorius J, Wood GC, Berger PB, Mascarenhas VH, Good CW, Scott TD, Blankenship JC.

J Interv Cardiol. 2013 Feb;26(1):14-21. doi: 10.1111/joic.12009. Epub 2012 Dec 30.

PMID:
23278363
30.

The occupational effects of interventional cardiology: results from the WIN for Safety survey.

Buchanan GL, Chieffo A, Mehilli J, Mikhail GW, Mauri F, Presbitero P, Grinfeld L, Petronio AS, Skelding KA, Hoye A, Mehran R, Morice MC; Women In Innovation Group.

EuroIntervention. 2012 Oct;8(6):658-63. doi: 10.4244/EIJV8I6A103.

31.

αCaMKII is differentially regulated in brain regions that exhibit differing sensitivities to ischemia and excitotoxicity.

Skelding KA, Spratt NJ, Fluechter L, Dickson PW, Rostas JA.

J Cereb Blood Flow Metab. 2012 Dec;32(12):2181-92. doi: 10.1038/jcbfm.2012.124. Epub 2012 Aug 29.

32.

Vascular Complications in Women and the Radial Approach.

Suryadevara RS, Skelding KA.

Interv Cardiol Clin. 2012 Apr;1(2):207-211. doi: 10.1016/j.iccl.2012.01.004. Epub 2012 Apr 10. Review.

PMID:
28582094
33.

The role of molecular regulation and targeting in regulating calcium/calmodulin stimulated protein kinases.

Skelding KA, Rostas JA.

Adv Exp Med Biol. 2012;740:703-30. doi: 10.1007/978-94-007-2888-2_31. Review.

PMID:
22453966
34.

Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II.

Skelding KA, Rostas JA, Verrills NM.

Cell Cycle. 2011 Feb 15;10(4):631-9. Epub 2011 Feb 15. Review.

PMID:
21301225
35.

SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel.

Best PJ, Skelding KA, Mehran R, Chieffo A, Kunadian V, Madan M, Mikhail GW, Mauri F, Takahashi S, Honye J, Hernández-Antolín R, Weiner BH; Society for Cardiovascular Angiography & Interventions' Women in Innovations (WIN) Group.

EuroIntervention. 2011 Feb;6(7):866-74. doi: 10.4244/EIJV6I7A148. Review.

PMID:
21252022
36.

SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel.

Best PJ, Skelding KA, Mehran R, Chieffo A, Kunadian V, Madan M, Mikhail GW, Mauri F, Takahashi S, Honye J, Hernández-Antolín R, Weiner BH; Women in Innovations (WIN) group of the Society of Cardiac Angiography and Intervention.

Heart Lung Circ. 2011 Feb;20(2):83-90. doi: 10.1016/j.hlc.2010.11.006. Review.

PMID:
21241961
37.

Door-to-balloon times under 90 min can be routinely achieved for patients transferred for ST-segment elevation myocardial infarction percutaneous coronary intervention in a rural setting.

Blankenship JC, Scott TD, Skelding KA, Haldis TA, Tompkins-Weber K, Sledgen MY, Donegan MA, Buckley JW, Sartorius JA, Hodgson JM, Berger PB.

J Am Coll Cardiol. 2011 Jan 18;57(3):272-9. doi: 10.1016/j.jacc.2010.06.056.

38.

Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride.

Skelding KA, Barry RD, Shafren DR.

Invest New Drugs. 2012 Apr;30(2):568-81. doi: 10.1007/s10637-010-9614-0. Epub 2010 Dec 21.

PMID:
21170760
39.

Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial.

Blankenship JC, Skelding KA, Scott TD, Berger PB, Parise H, Brodie BR, Witzenbichler B, Gaugliumi G, Peruga JZ, Lansky AJ, Mehran R, Stone GW.

Am J Cardiol. 2010 Dec 1;106(11):1527-33. doi: 10.1016/j.amjcard.2010.07.033. Epub 2010 Oct 14.

PMID:
21094350
40.

SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel.

Best PJ, Skelding KA, Mehran R, Chieffo A, Kunadian V, Madan M, Mikhail GW, Mauri F, Takahashi S, Honye J, Hernández-Antolín R, Weiner BH; Society for Cardiovascular Angiography & Interventions' Women in Innovations (WIN) group.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):232-41. doi: 10.1002/ccd.22877. Epub 2011 Jan 28.

PMID:
21061249
41.

Association of an INSIG2 obesity allele with cardiovascular phenotypes is gender and age dependent.

Skelding KA, Gerhard GS, Vlachos H, Selzer F, Kelsey SF, Chu X, Erdman R, Williams DO, Kip KE.

BMC Cardiovasc Disord. 2010 Sep 29;10:46. doi: 10.1186/1471-2261-10-46.

42.

Sex differences in percutaneous coronary interventions.

Lokhandwala JO, Skelding KA.

J Cardiovasc Transl Res. 2009 Sep;2(3):300-5. doi: 10.1007/s12265-009-9119-4. Epub 2009 Jul 15. Review.

PMID:
20560018
43.

Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative.

Chieffo A, Hoye A, Mauri F, Mikhail GW, Ammerer M, Grines C, Grinfeld L, Madan M, Presbitero P, Skelding KA, Weiner BH, Mehran R; WIN Group.

EuroIntervention. 2010 Feb;5(7):773-9.

PMID:
20142190
44.

Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative.

Chieffo A, Hoye A, Mauri F, Mikhail G, Ammerer M, Grines C, Grinfeld L, Madan M, Presbitero P, Skelding KA, Weiner BH, Mehran R.

Rev Esp Cardiol. 2010 Feb;63(2):200-8. English, Spanish.

45.

Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) Initiative.

Chieffo A, Hoye A, Mauri F, Mikhail GW, Ammerer M, Grines C, Grinfeld L, Madan M, Presbitero P, Skelding KA, Weiner BH, Mehran R; WIN Group; Women in Innovations Initiative.

Catheter Cardiovasc Interv. 2010 Feb 1;75(2):145-52. doi: 10.1002/ccd.22327.

PMID:
20095009
46.

Regulation of CaMKII by phospho-Thr253 or phospho-Thr286 sensitive targeting alters cellular function.

Skelding KA, Suzuki T, Gordon S, Xue J, Verrills NM, Dickson PW, Rostas JA.

Cell Signal. 2010 May;22(5):759-69. doi: 10.1016/j.cellsig.2009.12.011. Epub 2010 Jan 11.

PMID:
20060891
47.

Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.

Lokhandwala JO, Best PJ, Butterfield JH, Skelding KA, Scott T, Blankenship JC, Buckley JW, Berger PB.

Circ Cardiovasc Interv. 2009 Aug;2(4):348-51. doi: 10.1161/CIRCINTERVENTIONS.108.832964.108.832964. Epub 2009 Jul 22.

PMID:
20031738
48.

ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon time.

Blankenship JC, Skelding KA, Scott TD, Buckley J, Zimmerman DK, Temple A, Sartorius J, Jimenez E, Berger PB.

Am Heart J. 2009 Sep;158(3):400-7. doi: 10.1016/j.ahj.2009.06.022.

PMID:
19699863
49.

Regulation of CaMKII in vivo: the importance of targeting and the intracellular microenvironment.

Skelding KA, Rostas JA.

Neurochem Res. 2009 Oct;34(10):1792-804. doi: 10.1007/s11064-009-9985-9. Epub 2009 May 5. Review.

PMID:
19415486
50.

Feasibility and safety of ad hoc percutaneous coronary intervention in the modern era.

Good CW, Blankenship JC, Scott TD, Skelding KA, Berger PB, Wood GC.

J Invasive Cardiol. 2009 May;21(5):194-200.

PMID:
19411717

Supplemental Content

Loading ...
Support Center